Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Plasma matrix metalloproteinase-9 response to downhill running in humans.

Welsh MC, Allen DL, Byrnes WC.

Int J Sports Med. 2014 May;35(5):363-70. doi: 10.1055/s-0033-1353212. Epub 2013 Sep 18.

PMID:
24048912
2.

Serum concentrations of collagen degrading enzymes and their inhibitors after downhill running.

Koskinen SO, Höyhtyä M, Turpeenniemi-Hujanen T, Martikkala V, Mäkinen TT, Oksa J, Rintamäki H, Löfberg M, Somer H, Takala TE.

Scand J Med Sci Sports. 2001 Feb;11(1):9-15.

PMID:
11169229
3.

Plasma matrix metalloproteinase-9 response to eccentric exercise of the elbow flexors.

Madden MC, Byrnes WC, Lebin JA, Batliner ME, Allen DL.

Eur J Appl Physiol. 2011 Aug;111(8):1795-805. doi: 10.1007/s00421-010-1806-y. Epub 2011 Jan 11.

PMID:
21222132
4.

The effects of impact and non-impact exercise on circulating markers of collagen remodelling in humans.

Mackey AL, Donnelly AE, Swanton A, Murray F, Turpeenniemi-Hujanen T.

J Sports Sci. 2006 Aug;24(8):843-8.

PMID:
16815778
5.
6.

Imbalanced matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 activities in patients with thromboangiitis obliterans.

Dellalibera-Joviliano R, Jacob-Ferreira AL, Joviliano EE, Tanus-Santos JE, Evora PR.

Vasc Med. 2012 Apr;17(2):73-8. doi: 10.1177/1358863X11435979. Epub 2012 Mar 8.

PMID:
22402936
7.

Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in patients with tick-borne encephalitis.

Palus M, Zampachová E, Elsterová J, Růžek D.

J Infect. 2014 Feb;68(2):165-9. doi: 10.1016/j.jinf.2013.09.028. Epub 2013 Oct 1.

PMID:
24091083
9.

Muscle tenderness and peak torque changes after downhill running following a prior bout of isokinetic eccentric exercise.

Eston RG, Finney S, Baker S, Baltzopoulos V.

J Sports Sci. 1996 Aug;14(4):291-9.

PMID:
8887208
10.
11.

Seasonal variation and stability of matrix metalloproteinase-9 activity and tissue inhibitor of matrix metalloproteinase-1 with storage at -80°C.

Tarr GP, Williams MJ, Phillips LV, van Rij AM, Jones GT.

Clin Biochem. 2011 Nov;44(16):1346-8. doi: 10.1016/j.clinbiochem.2011.08.1139. Epub 2011 Sep 12.

PMID:
21939646
13.

Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.

Brunner S, Kim JO, Methe H.

Am J Cardiol. 2010 Feb 15;105(4):429-34. doi: 10.1016/j.amjcard.2009.10.013. Epub 2010 Jan 5.

PMID:
20152234
14.

Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.

Ylisirniö S, Höyhtyä M, Turpeenniemi-Hujanen T.

Anticancer Res. 2000 Mar-Apr;20(2B):1311-6.

PMID:
10810441
15.

Elevated plasma levels of TIMP-1 correlate with plasma suPAR/uPA in patients with chronic myeloproliferative disorders.

Jensen MK, Holten-Andersen MN, Riisbro R, de Nully Brown P, Larsen MB, Kjeldsen L, Heickendorff L, Brünner N, Hasselbalch HC.

Eur J Haematol. 2003 Nov;71(5):377-84.

PMID:
14667201
17.

Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.

Bauvois B, Mothu N, Nguyen J, Nguyen-Khoa T, Nöel LH, Jungers P.

Nephrol Dial Transplant. 2007 Apr;22(4):1115-22. Epub 2007 Jan 5.

PMID:
17205957
18.

[Plasma matrix metalloproteinases MMP-2 and MMP-9 and tissue inhibitors TIMP-1 and TIMP-2 in children treated for acute lymphoblastic leukemia].

Krawczuk-Rybak M, Kuźmicz M, Mroczko B, Szmitkowski M.

Pol Merkur Lekarski. 2010 Jul;29(169):14-8. Polish.

PMID:
20712241
19.

Altered plasma matrix metalloproteinase-9/tissue inhibitor of matrix [corrected] metalloproteinase-1 concentration during the early postoperative period in patients with colorectal cancer.

Kirman I, Jain S, Cekic V, Belizon A, Balik E, Sylla P, Arnell T, Forde KA, Whelan RL.

Surg Endosc. 2006 Mar;20(3):482-6. Epub 2006 Jan 21. Erratum in: Surg Endosc. 2006 Apr;20(4):706.

PMID:
16432654
20.

Circulating matrix metalloproteinase-8 (MMP-8) and MMP-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy.

Marcaccini AM, Novaes AB Jr, Meschiari CA, Souza SL, Palioto DB, Sorgi CA, Faccioli LH, Tanus-Santos JE, Gerlach RF.

Clin Chim Acta. 2009 Nov;409(1-2):117-22. doi: 10.1016/j.cca.2009.09.012. Epub 2009 Sep 12.

PMID:
19751716

Supplemental Content

Support Center